FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893270505> ?p ?o ?g. }

• W2893270505 endingPage "690" @default.
• W2893270505 startingPage "683" @default.
• W2893270505 abstract "The P2X7 receptor (P2X7R) is an adenosine triphosphate-gated ion channel that is predominantly expressed on microglial cells in the central nervous system. We report the clinical qualification of P2X7-specific PET ligand 18F-JNJ-64413739 in healthy volunteers, including dosimetry, kinetic modeling, test-retest variability, and blocking by the P2X7 antagonist JNJ-54175446. Methods: Whole-body dosimetry was performed in 3 healthy male subjects by consecutive whole-body PET/CT scanning, estimation of the normalized cumulated activity, and calculation of the effective dose using OLINDA (v1.1). Next, 5 healthy male subjects underwent a 120-min dynamic 18F-JNJ-64413739 PET/MRI scan with arterial blood sampling to determine the appropriate kinetic model. For this purpose, 1- and 2-tissue compartment models and Logan graphic analysis (LGA) were evaluated for estimating regional volumes of distribution (VT). PET/MRI scanning was repeated in 4 of these subjects to evaluate medium-term test-retest variability (interscan interval, 26-97 d). For the single-dose occupancy study, 8 healthy male subjects underwent baseline and postdose 18F-JNJ-64413739 PET/MRI scans 4-6 h after the administration of a single oral dose of JNJ-54175446 (dose range, 5-300 mg). P2X7 occupancies were estimated using a Lassen plot and regional baseline and postdose VTResults: The average (mean ± SD) effective dose was 22.0 ± 1.0 μSv/MBq. The 2-tissue compartment model was the most appropriate kinetic model, with LGA showing very similar results. Regional 2-tissue compartment model VT values were about 3 and were rather homogeneous across all brain regions, with slightly higher estimates for the thalamus, striatum, and brain stem. Between-subject VT variability was relatively high, with cortical VT showing an approximate 3-fold range across subjects. As for time stability, the acquisition time could be reduced to 90 min. The average regional test-retest variability values were 10.7% ± 2.2% for 2-tissue compartment model VT and 11.9% ± 2.2% for LGA VT P2X7 occupancy approached saturation for single doses of JNJ-54175446 higher than 50 mg, and no reference region could be identified. Conclusion:18F-JNJ-64413739 is a suitable PET ligand for the quantification of P2X7R expression in the human brain. It can be used to provide insight into P2X7R expression in health and disease, to evaluate target engagement by P2X7 antagonists, and to guide dose selection." @default.
• W2893270505 created "2018-10-05" @default.
• W2893270505 creator A5011600682 @default.
• W2893270505 creator A5033203914 @default.
• W2893270505 creator A5066111936 @default.
• W2893270505 creator A5068294771 @default.
• W2893270505 creator A5069275587 @default.
• W2893270505 creator A5069704967 @default.
• W2893270505 creator A5070271181 @default.
• W2893270505 creator A5072600244 @default.
• W2893270505 creator A5076699095 @default.
• W2893270505 creator A5078411722 @default.
• W2893270505 creator A5079224028 @default.
• W2893270505 creator A5079903461 @default.
• W2893270505 creator A5080344209 @default.
• W2893270505 creator A5081304921 @default.
• W2893270505 creator A5091337532 @default.
• W2893270505 date "2018-09-27" @default.
• W2893270505 modified "2023-10-15" @default.
• W2893270505 title "¹⁸F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446" @default.
• W2893270505 cites W1500980879 @default.
• W2893270505 cites W1940940153 @default.
• W2893270505 cites W1984436706 @default.
• W2893270505 cites W2010666651 @default.
• W2893270505 cites W2014863257 @default.
• W2893270505 cites W2053410363 @default.
• W2893270505 cites W2063017390 @default.
• W2893270505 cites W2084383502 @default.
• W2893270505 cites W2108602500 @default.
• W2893270505 cites W2127325484 @default.
• W2893270505 cites W2133942268 @default.
• W2893270505 cites W2137756761 @default.
• W2893270505 cites W2144624803 @default.
• W2893270505 cites W2146428873 @default.
• W2893270505 cites W2152089134 @default.
• W2893270505 cites W2159550615 @default.
• W2893270505 cites W2162427558 @default.
• W2893270505 cites W2165709201 @default.
• W2893270505 cites W2192342554 @default.
• W2893270505 cites W2285480544 @default.
• W2893270505 cites W2307510499 @default.
• W2893270505 cites W2396850479 @default.
• W2893270505 cites W2402724338 @default.
• W2893270505 cites W2417039123 @default.
• W2893270505 cites W2533636593 @default.
• W2893270505 cites W2560552801 @default.
• W2893270505 cites W2604576812 @default.
• W2893270505 cites W2608784477 @default.
• W2893270505 cites W2612684343 @default.
• W2893270505 cites W2729475301 @default.
• W2893270505 cites W2766237804 @default.
• W2893270505 cites W2773491363 @default.
• W2893270505 cites W2774859152 @default.
• W2893270505 cites W2805624515 @default.
• W2893270505 cites W2894218798 @default.
• W2893270505 cites W2914948709 @default.
• W2893270505 cites W4254055030 @default.
• W2893270505 doi "https://doi.org/10.2967/jnumed.118.216747" @default.
• W2893270505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30262518" @default.
• W2893270505 hasPublicationYear "2018" @default.
• W2893270505 type Work @default.
• W2893270505 sameAs 2893270505 @default.
• W2893270505 citedByCount "57" @default.
• W2893270505 countsByYear W28932705052019 @default.
• W2893270505 countsByYear W28932705052020 @default.
• W2893270505 countsByYear W28932705052021 @default.
• W2893270505 countsByYear W28932705052022 @default.
• W2893270505 countsByYear W28932705052023 @default.
• W2893270505 crossrefType "journal-article" @default.
• W2893270505 hasAuthorship W2893270505A5011600682 @default.
• W2893270505 hasAuthorship W2893270505A5033203914 @default.
• W2893270505 hasAuthorship W2893270505A5066111936 @default.
• W2893270505 hasAuthorship W2893270505A5068294771 @default.
• W2893270505 hasAuthorship W2893270505A5069275587 @default.
• W2893270505 hasAuthorship W2893270505A5069704967 @default.
• W2893270505 hasAuthorship W2893270505A5070271181 @default.
• W2893270505 hasAuthorship W2893270505A5072600244 @default.
• W2893270505 hasAuthorship W2893270505A5076699095 @default.
• W2893270505 hasAuthorship W2893270505A5078411722 @default.
• W2893270505 hasAuthorship W2893270505A5079224028 @default.
• W2893270505 hasAuthorship W2893270505A5079903461 @default.
• W2893270505 hasAuthorship W2893270505A5080344209 @default.
• W2893270505 hasAuthorship W2893270505A5081304921 @default.
• W2893270505 hasAuthorship W2893270505A5091337532 @default.
• W2893270505 hasBestOaLocation W28932705051 @default.
• W2893270505 hasConcept C126322002 @default.
• W2893270505 hasConcept C170493617 @default.
• W2893270505 hasConcept C2776885963 @default.
• W2893270505 hasConcept C2989005 @default.
• W2893270505 hasConcept C71924100 @default.
• W2893270505 hasConcept C75088862 @default.
• W2893270505 hasConceptScore W2893270505C126322002 @default.
• W2893270505 hasConceptScore W2893270505C170493617 @default.
• W2893270505 hasConceptScore W2893270505C2776885963 @default.
• W2893270505 hasConceptScore W2893270505C2989005 @default.
• W2893270505 hasConceptScore W2893270505C71924100 @default.
• W2893270505 hasConceptScore W2893270505C75088862 @default.
• W2893270505 hasIssue "5" @default.

• next